Controversial drug tested against rare blood disorder
NCT ID NCT00769587
Summary
This study tested whether thalidomide could help control aggressive mastocytosis, a rare condition where too many mast cells build up in the body. Patients with relapsed or progressive disease took thalidomide pills daily for six months. The main goal was to see if the drug could reduce the level of disease infiltration.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON NEOPLASTIC CONDITION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier Universitaire d'Amiens
Amiens, 80054, France
Conditions
Explore the condition pages connected to this study.